Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)

CNY 37.17

(0.38%)

Market Cap (In CNY)

11.98 Billion

Revenue (In CNY)

3.09 Billion

Net Income (In CNY)

800.91 Million

Avg. Volume

2.34 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
26.953846-45.12
PE
-
EPS
-
Beta Value
1.055
ISIN
CNE000000ZW7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yuan Dong Guo
Employee Count
-
Website
https://www.xzyy.cn
Ipo Date
1999-07-21
Details
Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.